Document Detail

Schiff plus click: one-pot preparation of triazole-substituted iminopyridines and ring opening of the triazole ring.
MedLine Citation:
PMID:  23212625     Owner:  NLM     Status:  Publisher    
The use of Schiff condensation followed by CuAAC affords complexes containing iminopyridine ligands functionalized either with a triazole ring or with a sulfonyl amido group via ring opening of the unstable sulfonyl triazole.
Celedonio M Alvarez; Luis A García-Escudero; Raúl García-Rodríguez; Daniel Miguel
Related Documents :
16204985 - Crystal structures of palladium(ii) ternary complexes of 5-x-2-aminobenzoic acid with 1...
19552445 - Copper-mediated direct arylation of 1,3,4-oxadiazoles and 1,2,4-triazoles with aryl iod...
15787575 - Neighboring group participation of 9-anthracenylmethyl group in glycosylation: preparat...
15506735 - Palladium-catalyzed synthesis of n-aryl-2-benzylindolines via tandem arylation of 2-all...
24098215 - Dipentyl 2,6-di-amino-benzo[1,2-b:4,5-b']di-furan-3,7-di-carboxyl-ate.
18177045 - Enhanced metal ion selectivity of 2,9-di-(pyrid-2-yl)-1,10-phenanthroline and its use a...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-12-5
Journal Detail:
Title:  Dalton transactions (Cambridge, England : 2003)     Volume:  -     ISSN:  1477-9234     ISO Abbreviation:  Dalton Trans     Publication Date:  2012 Dec 
Date Detail:
Created Date:  2012-12-5     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101176026     Medline TA:  Dalton Trans     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
GIR-MIOMeT-IU CINQUIMA/Química Inorgánica, Facultad de Ciencias, Universidad de Valladolid, Valladolid, Spain.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Fractional laser-assisted delivery of methyl aminolevulinate: Impact of laser channel depth and incu...
Next Document:  Recent updates on the development of ganetespib as a Hsp90 inhibitor.